Recent advances in understanding/managing trigeminal neuralgia.

Area of Science:

• Neurology
• Pain Management
• Pharmacology

Background:

• Trigeminal neuralgia (TN) management presents ongoing challenges despite therapeutic advancements.
• Accurate classification of facial pain and identification of prognostic factors are crucial for optimizing patient quality of life.

Purpose of the Study:

• To review current and emerging treatment strategies for trigeminal neuralgia.
• To highlight the need for better patient selection and outcome prediction for various interventions.

Main Methods:

• Literature review of pharmacological, non-pharmacological, and surgical treatments for trigeminal neuralgia.
• Discussion of established therapies like carbamazepine and novel approaches including botulinum neurotoxin type A and selective sodium channel blockers.

Main Results:

• Carbamazepine remains a primary treatment, though not originally developed for TN.
• Emerging options include botulinum neurotoxin type A, selective Na_v1.7 blockers (CNV1014802), and non-invasive brain stimulation (tDCS, rTMS).
• Surgical interventions like Gasserian ganglion techniques, gamma knife surgery, and microvascular decompression are options for refractory cases.

Conclusions:

• Trigeminal neuralgia treatment requires a multi-faceted approach, combining established and novel therapies.
• Further research is needed to evaluate emerging treatments and improve patient selection for surgical interventions.
• Continued efforts aim to refine surgical techniques and predict treatment outcomes for enhanced patient care.